He is an NIH-funded investigator in urology field, and his area of expertise is in pharmacology and intravesical drug delivery. He received his Ph.D. degree in pharmaceutical sciences from the University of Pittsburgh, Penn, USA, and after completing his postdoctoral training, he joined the faculty in 2006. He is nationally and internationally recognized for his work on the role of drug delivery and urine proteomics in lower urinary tract disorders. Among his current NIH- and DOD-funded work are investigations into the development of novel intravesical antisense therapies for OAB and interstitial cystitis. His contributions to the field have been published in leading biomedical research journals. Biography Updated on 3 April 2012